Navigation Links
Dell Laser Consultants is Among the First in Texas to offer the RxSight™ Light Adjustable Lens to Patients

Renowned eye surgical practice led by Steven J. Dell, MD, Dell Laser Consultants is among the first practices in Texas to offer the FDA-approved, post-surgical, corrective Light Adjustable Lens (LAL) by RxSight™. Since offering this technology in November 2019, nearly 100 LAL implants have been placed with excellent results. Dell Laser Consultants is also currently involved in the latest LAL FDA study.

The RxSight™ LAL is the first intraocular lens (IOL) that allows adjustments following cataract surgery, the first and only FDA-approved IOL of this nature. Before this technology, the refractive accuracy, which affects post-op visual outcomes, could not be precisely targeted, despite preoperative measurements and calculations. The LAL is a three-piece foldable design that is implanted just like a monofocal lens implant. A monofocal lens is a standard lens implant, which is typically covered by most insurance companies, such as Medicare. Unlike monofocal lenses, the Light Adjustable Lens is made with a special photoreactive silicone, which allows surgeons to adjust the prescription after implantation by using an advanced Ultra-Violet (UV) light.

Cataracts occur when the eye’s natural lens becomes clouded, most commonly the result of aging. While cataracts are one of the leading causes of blindness, the removal of cataracts is one of the safest and most common surgical procedures around in the world today. The Light Adjustable Lens technology in cataract surgery helps improve visual outcomes by allowing surgeons to make adjustments to the lens after the cataract is removed and the LAL is implanted.

“In the past, it could be difficult to get precise pre-operative measurements on patients that had previous refractive surgery such as LASIK or PRK. Now, we have the ability to fine-tune a patient’s visual results after surgery. This gives the patient the choice to correct both eyes for distance or correct the non-dominant eye for up-close vision, resulting in a more precise form of monovision. This level of precision has not been achievable until now, by using the Light Adjustable Lens,” said Dr. Steven J. Dell, Medical Director of Dell Laser Consultants.

In an FDA study which included 600 patients, those who received the LAL were twice as likely to achieve 20/20 vision without glasses, compared to those who received a standard monofocal lens.

“This technology has allowed us to offer exceptional visual results to patients that previously had to settle for lesser vision,” said Dr. Derek N. Cunningham, Director or Optometry at Dell Laser Consultants.

The ideal candidates for Light Adjustable Lens implants are patients that are concerned about their best possible distance vision, a patient wanting monovision, or patients with a history of corneal surgery including LASIK, PRK, or RK for irregular corneas.

About Dell Vision
Led by Steven J. Dell, MD, Dell Laser Consultants is a leading ophthalmology practice located in Austin, TX. Considered an international leader in refractive, cataract, and LASIK eye surgery, Dr. Dell is a board-certified ophthalmologist in Austin and the Medical Director of Dell Laser Consultants. He has dedicated his career to enhancing vision correction in the US and abroad, and he strives to provide each patient with exceptional, customized treatment and unparalleled results. An award-winning eye surgeon, Dr. Dell has been a featured presenter at major ophthalmology conferences around the world, where he helps to train other eye surgeons in the latest techniques. Furthermore, he is an advocate of continuing education, and his research has led to the development of some of the most advanced technologies available. Through his relationship with the FDA and several ophthalmic equipment manufacturers, he is able to provide patients with state-of-the-art innovations years ahead of other practices.

Read the full story at

Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved

Related biology news :

1. Future of Laser Innovations Reflected at Revamped ICALEO Conference
2. Italian Laser Manufacturer Quanta System SpA Signs Exclusive U.S. Distribution Agreement with Cartessa Aesthetics
3. Erchonia’s NEW FX 635 Laser for Chronic Low Back Pain will be Available at The National 2018
4. Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market
5. Laser-guided sea monkeys show how zooplankton migrations may affect global ocean currents
6. Symphony of nanoplasmonic and optical resonators produces laser-like light emission
7. Lasers and night-vision technology help improve imaging of hidden lymphatic system
8. Fighting cancer with lasers and nanoballoons that pop
9. Scientists prove X-ray laser can solve protein structures from scratch
10. Lasers might be the cure for brain diseases such as Alzheimers and Parkinsons
11. Lasers offer an automated way to test drinking water
Post Your Comments:
(Date:7/31/2020)... ... July 30, 2020 , ... Justin Zamirowski to ... a near term focus on Type 2 diabetes and associated comorbidities. , Justin ... therapeutic areas and classes. As Chief Commercial Officer, Justin will lead Better ...
(Date:7/18/2020)... ... ... Commercial launch readiness is a critical stage in a product life cycle. ... the global economic downturn will only increase price pressures overall for the industry. The ... value from every product launch is critical. However, history shows that only a third ...
(Date:7/4/2020)... PHOENIX (PRWEB) , ... July 03, 2020 , ... ... is proud to earn outstanding recognition and multiple awards for not only the ... the ABM portfolio, SoME® Skincare and Vivace® Microneedle RF. All the brands built ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 30, 2020 , ... ... life sciences industry, today announced the release of its signature product called ... Science Liaisons (MSLs) and other field medical professionals. , Beacon helps ...
(Date:7/18/2020)... ... July 16, 2020 , ... ... in the early detection and prevention of high-burden diseases, and Centric Consulting, a ... and healthcare organizations to utilize existing data in order to identify and prioritize ...
(Date:7/10/2020)... KONG (PRWEB) , ... July 09, 2020 , ... ... compound called 1-phenyl-2-thiourea (PTU) is commonly used to suppress pigment formation in zebrafish ... the PolyU research team led by Dr MA has been using the zebrafish ...
(Date:7/1/2020)... (PRWEB) , ... June 29, 2020 , ... ... year to date growth of 40% in 2020, despite many obstacles created as ... MedShift aims to increase revenue for its partnered medical practices and medical manufacturers ...
Breaking Biology Technology: